Coffin-Lowry Syndrome

Alternative Names

  • CLS
Back to search Result
WHO-ICD-10 version:2010

Congenital malformations, deformations and chromosomal abnormalities

Other congenital malformations

OMIM Number

303600

Mode of Inheritance

X-linked dominant

Gene Map Locus

Xp22.12

Description

Coffin-Lowry syndrome is a rare syndromic form of X-linked mental retardation characterized by psychomotor retardation and growth retardation, and various skeletal anomalies. The clinical presentation of this condition shows a remarkable variability. Affected patients tend to have a characteristic facies, including microcephaly, large nose, anteverted nares, hypertelorism, down-slanting palpebral fissures, maxillary hypoplasia, frontal bossing, and high vaulted/narrow palate. Males show moderate to severe mental retardation and developmental delay. Skeletal abnormalities include a short stature and spinal curvature. Some patients may have seizures. Sensorineural hearing defects are seen in about 30% of the patients. About 15% also have mitral regurgitation. Affected females have a much less severe form of the disease, with moderate mental retardation in the worst cases.

Diagnosis of the condition in males is based on the presence of moderate-to-severe developmental delay, characteristic craniofacial and hand findings, and radiographic findings. Confirmation of the diagnosis requires the identification of mutations in the RPS6KA3 gene. Early diagnosis is important for proper management. Patients need to be followed up for potential hearing impairment, dental and ocular complications, and cardiac defects. Management is symptomatic. Seizures and drop attacks can be managed with the help of medications. Worsening kyposcoliosis may require surgical correction. Coffin-Lowry syndrome has an estimated incidence of 1:50,000 to 1:100,000.

Molecular Genetics

Nearly 70-80% of patients affected with Coffin-Lowry syndrome appear as sporadic cases, with no family history of the condition. Coffin-Lowry syndrome is an X-linked monogenic disorder caused by mutation of the RPS6KA3 gene located on the short arm of the X chromosome. This gene codes for a protein, RSK2, which is a growth factor-regulated serine-threonine protein kinase acting on the distal end of the RAS-MAP kinase signaling pathway. Animal studies have suggested that normal functioning of this protein is required for neuronal development and function.

Epidemiology in the Arab World

View Map

Other Reports

Kuwait

Farag et al. (1993) conducted a clinicogenetic assessment of 400 institutionalized mentally retarded (IQ less than 50) Kuwaiti patients during a 4-year period (1986-1990). Two patients were diagnosed with Coffin-Lowry syndrome.

© CAGS 2024. All rights reserved.